Determinants of dopaminergic neuron loss in Parkinson's disease

The FEBS Journal
D James Surmeier

Abstract

The cardinal motor symptoms of Parkinson's disease (PD) are caused by the death of dopaminergic neurons in the substantia nigra pars compacta (SNc). Alpha-synuclein (aSYN) pathology and mitochondrial dysfunction have been implicated in PD pathogenesis, but until recently it was unclear why SNc dopaminergic neurons should be particularly vulnerable to these two types of insult. In this brief review, the evidence that SNc dopaminergic neurons have an anatomical, physiological, and biochemical phenotype that predisposes them to mitochondrial dysfunction and synuclein pathology is summarized. The recognition that certain traits may predispose neurons to PD-linked pathology creates translational opportunities for slowing or stopping disease progression.

References

Jun 3, 1989·Lancet·A H SchapiraC D Marsden
Jun 25, 1984·Brain Research·E ScarnatiC Pacitti
Aug 26, 1998·Biochimica Et Biophysica Acta·D G Nicholls, S L Budd
May 3, 2000·The European Journal of Neuroscience·M TakadaH Imai
Oct 26, 2001·Journal of Neurochemistry·T V Votyakova, I J Reynolds
Nov 19, 2002·Journal of Neurobiology·Fu-Ming ZhouJohn A Dani
Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
Sep 1, 2004·Cell and Tissue Research·Heiko BraakKelly Del Tredici
Sep 21, 2004·Journal of Bioenergetics and Biomembranes·Serge PrzedborskiMiquel Vila
Jul 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel M HuseGregory Lenhart
May 23, 2006·Lancet Neurology·Lonneke M L de Lau, Monique M B Breteler
Sep 27, 2006·Brain Research·Yasin TemelHarry W M Steinbusch
Jan 20, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michelino PuopoloBruce P Bean
Apr 10, 2007·Trends in Neurosciences·David Sulzer
Apr 26, 2007·The American Journal of Pathology·Brian M DuftyTroy T Rohn
May 2, 2007·Brain : a Journal of Neurology·Chaorui HuangDavid Eidelberg
May 22, 2007·Nature Reviews. Neuroscience·Bruce P Bean
Jun 15, 2007·Nature·C Savio ChanD James Surmeier
Oct 27, 2007·Neuropathology and Applied Neurobiology·C H HawkesH Braak
Feb 8, 2008·Neurology·Claudia BeckerChristoph R Meier
Apr 9, 2008·Nature Medicine·Jeffrey H KordowerC Warren Olanow
Jul 8, 2008·Journal of Neurology·Andreas BenderThomas Klopstock
Jan 16, 2009·Trends in Cell Biology·Teruo HayashiTsung-Ping Su
Jan 16, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Wakoto MatsudaTakeshi Kaneko
Aug 14, 2009·Journal of Neurophysiology·R C FoehringJ C Callaway
Sep 4, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jaime N GuzmanD James Surmeier
Dec 8, 2009·Journal of Bioenergetics and Biomembranes·Teresa G Hastings
Dec 17, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ilva PutzierEdwin S Levitan
Jan 26, 2010·Trends in Pharmacological Sciences·J Timothy GreenamyrePier-Giorgio Mastroberardino
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Mark R Cookson
May 28, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zayd M Khaliq, Bruce P Bean
Jun 29, 2010·Nature Neuroscience·Esther Wong, Ana Maria Cuervo

❮ Previous
Next ❯

Citations

Oct 5, 2018·Current Neurology and Neuroscience Reports·S L SisonA D Ebert
Oct 9, 2018·The FEBS Journal·Andrey Y Abramov
Aug 25, 2019·Molecular Psychiatry·Karl GrenierPhedias Diamandis
Aug 21, 2019·Cold Spring Harbor Perspectives in Biology·Sean SchrankGrace E Stutzmann
Jul 6, 2020·Journal of Neuroscience Research·Jinelle M Wint, Howard I Sirotkin
Jul 8, 2020·Journal of Neuroscience Research·Vania Macías-CalvioMaría-Paz Marzolo
Jul 16, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Iara Pérez-TaboadaMario Vallejo
May 20, 2020·The Journal of Biological Chemistry·Zachary A Sorrentino, Benoit I Giasson
Jan 16, 2019·Journal of Neural Transmission·Fanni F GeiblWolfgang H Oertel
Apr 22, 2019·Acta Neuropathologica·Javier Alegre-AbarrateguiChristos Proukakis
Sep 17, 2019·The Journal of Clinical Investigation·Rong CaiLei Liu
Oct 6, 2020·Frontiers in Cell and Developmental Biology·Qiang HeWei Lu
Mar 16, 2019·Acta Neuropathologica Communications·Xinhe WangJiyan Ma
Dec 18, 2019·Nature Neuroscience·Rongmin Chen, Elizabeth A Jonas
Jul 30, 2020·Molecular Neurobiology·Ajmal AhmadMohammad Moshahid Khan
Jun 27, 2019·Journal of Neural Transmission·Peter RiedererCamelia-Maria Monoranu
May 20, 2020·International Journal of Molecular Sciences·Sandra Barata-AntunesAntónio J Salgado
Oct 23, 2020·The FEBS Journal·Maria Markaki, Nektarios Tavernarakis
Nov 18, 2020·Clinical and Translational Science·Juhee KangJaerak Chang
Dec 17, 2020·Cell Death and Differentiation·Chiara MilanesePier G Mastroberardino
Jan 3, 2021·Journal of Neuroscience Methods·Jacob F NormanJohn A White
Feb 2, 2021·Journal of Parkinson's Disease·Zijuan ZhangChristian Hölscher
Mar 22, 2019·Neuron·Matthew M McGregor, Alexandra B Nelson
Apr 27, 2021·Brain Research Bulletin·Rahimah HassanZurina Hassan
May 4, 2021·Frontiers in Cellular Neuroscience·Sarah ThrelfellKatherine R Brimblecombe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.